
Twin wins for Indian auto sector in free-trade pact with UK
The India-UK Comprehensive Economic and Trade Agreement (CETA) also protects the domestic clean mobility market for electric and hybrid vehicles by offering no concessions to the UK. 'India shall not provide any out-of-quota preferential customs duty on zero emission vehicles (electric, hybrid or hydrogen fuel vehicles),' the trade documents by the UK government said.
Protecting India's clean mobility manufacturing is crucial as demand for electric and hybrid vehicles rises. While hybrid vehicle sales rose about 12% year-on-year to 365,024 in FY25, pure electric vehicle (EV) sales rose 17% to 1,967,313 units, showed data from the central government's Vahan portal.
However, concessions offered by India, the world's third-largest auto market by sales, will make luxury car imports from the UK cheaper for Indian consumers. Models from companies including Tata Group-owned Jaguar Land Rover, Aston Martin, and Rolls-Royce can get cheaper in India, which saw 51,000 luxury car sales in FY25.
Indian Prime Minister Narendra Modi signed the historic bilateral deal in the UK on Thursday for goods and services trade between the two nations. The pact, which cemented concessions in trade by both nations, laid out a plan for gradually reducing import duties on various products for at least 10 years.
For some goods such as UK-made fossil fuel cars and high-end hybrid, electric, and hydrogen vehicles, the agreement lays out a 15-year plan of gradual duty reduction.
As per the CETA, India has agreed to gradually reduce tariffs on British luxury cars, with a maximum 37,000 cars seeing base tariffs at 10% in the fifth year after the agreement. From thereon, the number of cars allowed at this rate would reduce eventually to 15,000 at the end of 15th year.
'The proposed reduction in customs duty to 10% on all type of UK-manufactured vehicles over a period 10 years for EVs and five years for other cars—subject to defined quotas and eligibility norms—are expected to make premium cars significantly more accessible to Indian consumers,' said Saurabh Agarwal, partner and automotive tax leader, EY India.
India has agreed to relax the tariffs on a specific quota each year, going up to 19,000 in the fifth year and then gradually coming down to 7,500 cars. This will be applicable to petrol cars above 3,000 cc engines and diesel cars of 2,500 cc. Different quotas have been announced for 1,500 cc to 2,500 cc level and up to 1,500 cc. Overall, 37,000 internal combustion engine (ICE) passenger cars will be allowed by the government.
Indian companies that stand to benefit include TVS Motor Co., which has a UK subsidiary, Norton Motorcycles; and Hero MotoCorp Ltd, which plans to enter the UK market in the second half of the current financial year.
'As a company with a strong presence in both India and the UK, we at TVS Supply Chain Solutions see this FTA as a strategic enabler. It will help streamline trade flows, reduce operational friction, and accelerate our ability to deliver cost-effective, agile solutions to global customers,' said R. Dinesh, chairman at the company. 'With our strong presence in the UK and India , the agreement further strengthens our position in a critical market while opening new doors for cross-border collaboration, investment, and innovation.'
The FTA will protect the interests of Indian automakers and component manufacturers that rely on schemes such as the ₹ 25,938 crore production-linked incentives for automobiles and automotive components (PLI-Auto). Indian electric vehicle makers, seeking benefits under the PLI-Auto scheme, have invested over ₹ 25,000 crore in capital.
Component makers are also expecting a boost as their exports will get a relief in the UK. In FY25, auto component players exported $6.75 billion worth of goods to Europe, a part of which goes to the UK.
'The CETA is expected to benefit the Indian auto component sector through enhanced opportunities for exports, streamlined regulatory processes, particularly in key areas such as electric mobility, precision engineering, and lightweight materials,' said Shraddha Suri Marwah, president of the Automotive Component Manufacturers Association of India (ACMA).
'Indian MSMEs, which form the backbone of our industry, stand to gain from the liberalized terms of trade and improved access to UK markets.'
Experts said the India-UK CETA cemented a clear path for bilateral trade in the auto sector, with clear benefits outlined for Indian exports.
'The India-UK free-trade agreement is a strategic milestone for the automotive sector, reducing import tariffs on UK vehicles from over 100% to 10% within quota limits, while ensuring 99% duty-free access for Indian exports,' said Pratik Shah, partner, EY-Parthenon.
'With a growing base of auto component & vehicle exports from India, the agreement sets the stage for stronger bilateral trade, deeper supply chain integration, and increased jobs and investment flows,' Shah said.
But there were still some challenges related to carbon taxation, and protecting local manufacturing was a key outcome of the deal. 'While there are few concerns around backdoor Chinese imports and UK's carbon border adjustment mechanism (CBAM) levies, long-term success hinges on balancing collaboration with protecting local innovation,' said Shah.
India has also agreed to gradually reduce the levy on importing trucks from the UK from 37% in the first year to 8.8% by the 10th year of the agreement. The earlier base levy for trucks was 44%. This agreement comes with an annual quota ranging from 2,500 completely built-up units in the first year to 3,500 units for the 10th year onwards.
In case more trucks are imported from the UK than the annual quota for a particular year, there will be a higher levy ranging from 41.8% in the first year to 22% for the 10th year onwards.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
23 minutes ago
- Mint
Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs
By Bharath Rajeswaran and Vivek Kumar M (Reuters) -Indian shares inched lower on Monday as weak results from Kotak Mahindra Bank weighed on sentiment, while uncertainty over trade talks with the U.S. added to overall caution. The Nifty 50 fell 0.16% to 24,798.9 points and the BSE Sensex lost 0.2% to 81,325.4 as of 10:03 a.m. IST. The broader small-caps and mid-caps lost 0.3% and 0.2%, respectively. Negotiations between India and the United States remained deadlocked over tariff cuts on agriculture and dairy products, dimming hopes of an interim deal ahead of U.S. President Donald Trump's August 1 deadline. This is in contrast to a framework trade agreement struck between the U.S. and European Union over the weekend, easing fears of a bigger trade war between the two allies, which account for almost a third of global trade. High-weightage financials and private banks lost 0.2% and 1%, respectively, dragged by a 7% fall in Kotak Mahindra Bank after it posted a drop in quarterly profit. The IT index lost 0.5%, with Tata Consultancy Services shedding 1.6% after it announced plans to reduce its workforce by 2% in fiscal year 2026. The Nifty 50 and 30-stock Sensex have logged four consecutive weekly losses due to weak earnings, foreign outflows and uncertainty over the U.S.-India trade deal. "A dull earnings season and the lingering delay in the India-U.S. trade deal have clearly cast a shadow on market sentiment. With valuations still stretched across the board, investors are understandably treading with heightened caution," said G Chokkalingam, founder and head of research at Equinomics Research. Among individual stocks, Mphasis gained 2.4% on posting quarterly results in-line with estimates and on strong deal bookings, which has boosted the IT company's revenue growth outlook. SBI Cards and Payment Services lost 3.7% after missing profit estimates in the June quarter. (Reporting by Vivek Kumar M and Bharath Rajeswaran; Editing by Eileen Soreng and Mrigank Dhaniwala)


Mint
23 minutes ago
- Mint
BEL share price: Defence stock dips ahead of Q1 results 2025. Should you buy?
Defence stock Bharat Electronics (BEL) share price fell half a percent to its day's low of ₹ 393.10 in morning trade on Monday, July 28, ahead of its June quarter (Q1FY26) results. In the last 1 year, the stock advanced over 27 percent. Moreover, it fell over 6 percent in July so far after 4 months of gains. It rose 9.5 percent in June, 22.5 percent in May, 4.2 percent in April and 22.4 percent in March. However, it started the year on a negative note, down 16 percent in February after a flat January. Seema Srivastava, Senior Research Analyst at SMC Global Securities believes, "Bharat Electronics Ltd (BEL) is expected to report a steady financial performance, supported by a strong order book and continued focus on indigenisation under the Make-in-India initiative. Despite a seasonally weaker first quarter, the company remains well-positioned due to the healthy execution of defence contracts and a robust pipeline, including large-value orders aligned with emergency procurement initiatives. Strategic investments in R&D and localisation are expected to drive long-term growth while supporting margins and profitability. Investors will likely focus on operating margin trends, working capital discipline, and capex updates." Bharat Electronics Ltd (BEL) reported strong earnings for the fourth quarter of FY25, with net profit rising 18 percent year-on-year to ₹ 2,127 crore, compared to ₹ 1,797 crore in the same period last year. The state-run defence electronics major also posted a 7 percent increase in revenue from operations at ₹ 9,150 crore, up from ₹ 8,564 crore in the year-ago quarter. On a sequential basis, BEL delivered an impressive performance. Profit after tax (PAT) surged 62 percent from ₹ 1,312 crore in Q3FY25, while revenue jumped 59 percent from ₹ 5,771 crore in the October–December 2024 period. For the full financial year ended March 2025, BEL reported a 34 percent increase in PAT to ₹ 5,323 crore, up from ₹ 3,985 crore in FY24. Revenue from operations for the year rose to ₹ 23,769 crore, a 17 percent improvement over the ₹ 20,268 crore reported in the previous financial year. As of April 1, 2025, BEL's total order book stood at a healthy ₹ 71,650 crore, indicating a strong pipeline and sustained business momentum in the defence and allied sectors. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.


Economic Times
23 minutes ago
- Economic Times
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.